HRT Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.1M | Buy |
74,818
+16,085
| +27% | +$3.88M | 0.08% | 126 |
|
|
2025
Q1 | $14.3M | Buy |
+58,733
| New | +$14.3M | 0.09% | 141 |
|
|
2024
Q4 | – | Sell |
-44,520
| Closed | -$14.9M | – | 2234 |
|
|
2024
Q3 | $14.9M | Buy |
+44,520
| New | +$14.9M | 0.07% | 158 |
|
|
2024
Q2 | – | Sell |
-2,053
| Closed | -$710K | – | 2058 |
|
|
2024
Q1 | $710K | Buy |
2,053
+355
| +21% | +$123K | ﹤0.01% | 1012 |
|
|
2023
Q4 | $548K | Sell |
1,698
-16,447
| -91% | -$5.31M | ﹤0.01% | 1205 |
|
|
2023
Q3 | $6.5M | Buy |
18,145
+15,320
| +542% | +$5.49M | 0.06% | 201 |
|
|
2023
Q2 | $1.07M | Sell |
2,825
-3,406
| -55% | -$1.29M | 0.01% | 850 |
|
|
2023
Q1 | $2.98M | Buy |
6,231
+4,856
| +353% | +$2.33M | 0.04% | 411 |
|
|
2022
Q4 | $578K | Buy |
1,375
+39
| +3% | +$16.4K | 0.01% | 1219 |
|
|
2022
Q3 | $557K | Buy |
+1,336
| New | +$557K | 0.01% | 1291 |
|
|
2022
Q2 | – | Sell |
-933
| Closed | -$525K | – | 2849 |
|
|
2022
Q1 | $525K | Sell |
933
-4,572
| -83% | -$2.57M | ﹤0.01% | 1430 |
|
|
2021
Q4 | $4.16M | Buy |
+5,505
| New | +$4.16M | 0.02% | 324 |
|
|
2021
Q3 | – | Sell |
-4,951
| Closed | -$3.19M | – | 3009 |
|
|
2021
Q2 | $3.19M | Buy |
+4,951
| New | +$3.19M | 0.03% | 411 |
|
|
2021
Q1 | – | Sell |
-1,604
| Closed | -$935K | – | 2476 |
|
|
2020
Q4 | $935K | Buy |
+1,604
| New | +$935K | 0.02% | 674 |
|
|
2020
Q3 | – | Sell |
-22,444
| Closed | -$10.1M | – | 1812 |
|
|
2020
Q2 | $10.1M | Buy |
+22,444
| New | +$10.1M | 0.3% | 60 |
|